NPY nerve terminals form predominantly inhibitory synapses directly onto CRF neurons in the mouse amygdala — the first ultrastructural proof of how the brain's 'resilience' peptide may physically suppress the stress response.
~85% inhibitory synapsesNPY terminals overwhelmingly form symmetric (inhibitory-type) connections onto CRF neurons in the central amygdala
What the researchers found
For the first time, researchers provided ultrastructural evidence that neuropeptide Y (NPY) nerve terminals make direct synaptic contact with corticotropin-releasing factor (CRF) neurons in the central nucleus of the amygdala (CeA). Of 163 NPY terminals analyzed, approximately 85% formed symmetric (inhibitory) synapses with CRF dendrites, while only ~1% formed asymmetric (excitatory) synapses.
This anatomical wiring diagram reveals the physical basis for how NPY — the brain's 'stress resilience' peptide — may counteract CRF, the peptide that orchestrates the stress response. The overwhelming predominance of inhibitory-type connections suggests NPY primarily dampens CRF neuron activity.
Why it matters
The balance between NPY (calming) and CRF (stress-activating) in the amygdala is thought to determine stress resilience vs. vulnerability. When this balance tips toward CRF, it may contribute to anxiety, PTSD, and alcohol use disorders. This study provides the first anatomical proof that NPY directly synapses onto CRF neurons — confirming that the interaction is a direct neural circuit, not just a general chemical influence. This specificity matters for developing targeted treatments.
The numbers in context
163 NPY terminals analyzed · ~85% form symmetric (inhibitory) synapses with CRF dendrites · ~1% form asymmetric (excitatory) synapses · Central nucleus of amygdala (CeA) · Mouse brain
How the study worked
Researchers used two complementary microscopy techniques on mouse brain tissue: immunofluorescence microscopy to visualize NPY-labeled processes contacting CRF neurons, and electron microscopy with dual labeling (immunoperoxidase for NPY, gold-silver for CRF) to identify the exact synaptic connections at ultrastructural resolution. Semi-quantitative analysis classified synapse types.
Who was studied
Mouse brain tissue (central nucleus of the amygdala)
What this study cannot tell us
This is a preprint (bioRxiv) that has not yet undergone peer review. The study is purely anatomical — it shows physical connections but doesn't demonstrate functional inhibition of CRF neurons by NPY at these synapses. The mouse amygdala may differ from the human amygdala. The sample involved a limited number of animals (not specified).
How to read the evidence
This is a preliminary anatomical study published as a bioRxiv preprint (not yet peer-reviewed). While the electron microscopy data is detailed and the finding is novel, it demonstrates structure rather than function and has not undergone formal peer review.
When this study was published
Published as a 2025 preprint on bioRxiv. As a preprint, it has not yet been peer-reviewed. The findings should be considered preliminary until published in a peer-reviewed journal.
The bigger picture
NPY has been studied as a potential treatment target for anxiety, PTSD, and alcohol use disorder, with military studies showing that soldiers with higher NPY levels handle stress better. CRF hyperactivity is implicated in multiple psychiatric disorders. This study provides the anatomical proof that these two systems are directly wired together in the amygdala — the brain's fear and emotion center — validating the theoretical framework that has driven decades of NPY/CRF research.
Questions still open
- Does NPY actually inhibit CRF neuron firing through these symmetric synapses, or do the connections serve a different functional purpose?
- Is this NPY-CRF synaptic organization conserved in the human amygdala?
- Could drugs that enhance NPY signaling at these specific CRF-neuron synapses provide targeted treatment for stress-related disorders?
Common questions
What are NPY and CRF and why does their interaction matter?
Why is finding a direct synapse important versus just knowing both peptides are in the same brain region?
Read the original research
Subcellular interactions of neuropeptide Y and corticotropin-releasing factor in the central nucleus of the amygdala in the mouse.
bioRxiv : the preprint server for biology
Citation
Yerraguntla, Himavarsha; Onyekachi, Joy; Giacometti, Laura L; Goldberg, Samuel L; Barson, Jessica R; Barker, Jacqueline M; Reyes, Beverly A S. (2025). Subcellular interactions of neuropeptide Y and corticotropin-releasing factor in the central nucleus of the amygdala in the mouse.. bioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.09.19.677477